# Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT

> **NCT00774527** · PHASE3 · COMPLETED · sponsor: **Cooperative Study Group A for Hematology** · enrollment: 82 (actual)

## Conditions studied

- Bone Marrow Failure Syndromes

## Interventions

- **DRUG:** Cyclophosphamide-fludarabine-anti thymocyte globulin

## Key facts

- **NCT ID:** NCT00774527
- **Lead sponsor:** Cooperative Study Group A for Hematology
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2010-02
- **Final completion:** 2011-01
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2011-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774527, "Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00774527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*